{"slug":"ozempic-vs-victoza)","question":"Ozempic vs Victoza","answer":"Ozempic and Victoza are both GLP-1 receptor agonists, but Ozempic is dosed weekly while Victoza requires daily injections, and Ozempic has demonstrated superior weight loss results (average 15% body weight reduction vs. 5-6% for Victoza) in clinical trials.","answer_curated":true,"verdict":"Choose Ozempic if you prioritize maximum weight loss, need better cardiovascular protection, and prefer weekly dosing for convenience and compliance. Choose Victoza if you have a longer history with the medication class, prefer a more conservative approach for your first GLP-1 therapy, or have insurance limitations, though Ozempic's superior efficacy makes it the preferred first-line option for most patients with type 2 diabetes.","keyDifferences":[{"label":"Injection Frequency","winner":"a","entityAValue":"Once weekly","entityBValue":"Once daily"},{"label":"Average Weight Loss","winner":"a","entityAValue":"15% body weight (SUSTAIN-6 trial)","entityBValue":"5-6% body weight"},{"label":"FDA Indication for Type 2 Diabetes","winner":"tie","entityAValue":"Yes, approved 2017","entityBValue":"Yes, approved 2010"},{"label":"GLP-1 Agonist Class","winner":"a","entityAValue":"Long-acting (semaglutide)","entityBValue":"Short-acting (liraglutide)"},{"label":"Cardiovascular Outcome Trial","winner":"a","entityAValue":"SUSTAIN-6: 26% reduction in cardiovascular events","entityBValue":"LEADER: 13% reduction in cardiovascular events"}],"winner":{"slug":"ozempic-semaglutide","name":"Ozempic (semaglutide)"},"confidence":"high","entities":[{"name":"Ozempic (semaglutide)","slug":"ozempic-semaglutide","url":"https://www.aversusb.net/entity/ozempic-semaglutide","alternativesUrl":"https://www.aversusb.net/api/v1/alternatives/ozempic-semaglutide"},{"name":"Victoza (liraglutide)","slug":"victoza-liraglutide","url":"https://www.aversusb.net/entity/victoza-liraglutide","alternativesUrl":"https://www.aversusb.net/api/v1/alternatives/victoza-liraglutide"}],"faqs":[{"question":"Which medication causes more weight loss?","answer":"Ozempic produces substantially more weight loss, with clinical trials (SUSTAIN-6) showing 15% average body weight reduction compared to Victoza's 5-6% reduction. This difference is significant enough that many endocrinologists now prefer Ozempic as first-line therapy for patients whose primary goal includes weight management alongside diabetes control."},{"question":"Is Ozempic better for your heart?","answer":"Yes, Ozempic shows superior cardiovascular benefits with a 26% reduction in major adverse cardiovascular events in the SUSTAIN-6 trial versus Victoza's 13% reduction in the LEADER trial. Both are GLP-1 agonists with cardiovascular benefits, but Ozempic's longer-acting formulation and higher dose potential contribute to more robust outcomes."},{"question":"Why would someone still choose Victoza over Ozempic?","answer":"Victoza remains appropriate for patients who: (1) have established tolerance to the medication with 16 years of clinical data, (2) face insurance barriers or cost concerns (typically $300-400 cheaper per month), (3) prefer a more gradual/conservative approach as a first GLP-1 therapy, or (4) have difficulty tolerating once-weekly dosing schedules. However, most new patients now initiate Ozempic due to superior efficacy."}],"attribution":{"source":"A Versus B","url":"https://www.aversusb.net/compare/ozempic-vs-victoza)","license":"CC BY 4.0","citationFormat":"According to A Versus B (https://www.aversusb.net/compare/ozempic-vs-victoza)), Ozempic and Victoza are both GLP-1 receptor agonists, but Ozempic is dosed weekly while Victoza requires daily injections, and Ozempic has demonstrated superior weight loss results (average 15% body w","dateModified":"2026-07-03T15:39:21.447Z"},"relatedQuestionsUrl":"https://www.aversusb.net/api/faq/ozempic-vs-victoza)","relatedComparisonsUrl":"https://www.aversusb.net/api/v1/related/ozempic-vs-victoza)","knowledgeGraphUrl":"https://www.aversusb.net/api/knowledge-graph/ozempic-vs-victoza)","claimReviewSchema":{"@context":"https://schema.org","@type":"ClaimReview","@id":"https://www.aversusb.net/compare/ozempic-vs-victoza)#claimreview","url":"https://www.aversusb.net/compare/ozempic-vs-victoza)","claimReviewed":"Ozempic vs Victoza","reviewBody":"Ozempic and Victoza are both GLP-1 receptor agonists, but Ozempic is dosed weekly while Victoza requires daily injections, and Ozempic has demonstrated superior weight loss results (average 15% body weight reduction vs. 5-6% for Victoza) in clinical trials.","datePublished":"2026-07-03T15:39:20.937Z","dateModified":"2026-07-03T15:39:21.447Z","reviewRating":{"@type":"Rating","ratingValue":5,"worstRating":1,"bestRating":5,"alternateName":"High Confidence"},"author":{"@type":"Organization","@id":"https://www.aversusb.net/#organization","name":"A Versus B","url":"https://www.aversusb.net"},"itemReviewed":{"@type":"WebPage","@id":"https://www.aversusb.net/compare/ozempic-vs-victoza)","url":"https://www.aversusb.net/compare/ozempic-vs-victoza)","name":"Ozempic vs Victoza"}}}